Markovic U, Leotta V, Tibullo D, Giubbolini R, Romano A, Del Fabro V, Parrinello NL, Cannizzaro MT, Di Raimondo F, Conticello C. Serum free light chains and multiple myeloma: Is it time to extend their application?
Clin Case Rep 2020;
8:617-624. [PMID:
32274022 PMCID:
PMC7141730 DOI:
10.1002/ccr3.2636]
[Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 11/14/2019] [Accepted: 12/01/2019] [Indexed: 02/06/2023] Open
Abstract
In nonsecretory, oligo-secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti-MM agents.
Collapse